Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Prometic
Sort By
Newest First
1 / 1
1 / 1
Designation
Prometic receives Rare Pediatric Disease Designation from U.S. FDA for small molecule drug candidate, PBI-4050
Prometic
PR-M08-18-NI-068
Aug 16, 2018
Drug Candidate
Prometic Presents New Data on NASH Drug Candidate PBI-4547
Prometic
PR-M06-18-NI-080
Jun 25, 2018
